AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1563120
Drug: Testosterone treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone treatment (for boys with initial growth velocity below mean of healthy control group)
Trial: 1563120
Drug: Testosterone treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone treatment (for boys with initial growth velocity normal)
Trial: 3161613
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of MPA daily (Group 1)
Trial: 3161613
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of MPA (Group 2)
Trial: 26283739
Drug: Liraglutide (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (titrated to a maximum dose of 1.8 mg)
Trial: 17548781
Drug: Olanzapine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (1 to 20 mg/d)
Trial: 11699044
Drug: Highly active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly active antiretroviral therapy (HAART) including AZT or D4T plus 3TC and either IND, NELF, RITV, or SAQ at standard dosage
Trial: 3675893
Drug: Paper prosthesis
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paper prosthesis treatment group
Trial: 28755971
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate tablet (200mg)
Trial: 15003079
Drug: Pindolol, 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol, 2.5 mg t.i.d.
Trial: 15003079
Drug: Sham augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham augmentation (Control)
Trial: 11716199
Drug: Budesonide Easyhaler
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide Easyhaler and Turbuhaler (both doses)
Trial: 26066651
Drug: Intensive handwashing
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive handwashing promotion (soap and daily handwashing promotion)
Trial: 19169852
Drug: Aspirin after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin after endovascular coiling
Trial: 19169852
Drug: Aspirin after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin after neurosurgical clipping
Trial: 9394693
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg Zn/d (zinc supplementation)
Trial: 2431864
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg oral dose of cocaine hydrochloride
Trial: 28177714
Drug: High-protein intake
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-protein intake (HiPROT) at 1.45 g protein/(kg body mass·day) plus 0.72 g branched-chain amino acids per day during BR
Trial: 28177714
Drug: Control (CON)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (CON) group receiving 1 g/(kg body mass·day) dietary protein
Trial: 23263742
Drug: Casein hydrolysate
RxNorm normalized name: casein hydrolysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casein hydrolysate solution (PRO) - 20 g before, 10 g during, 20 g post-exercise
Trial: 16877725
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa (EPO) 600 units/kg to 900 units/kg, administered intravenously once-weekly for 16 weeks
Trial: 12969089
Drug: Tetracycline 500
RxNorm normalized name: oxytetracycline 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline 500 mg q.d.s., metronidazole 500 mg t.d.s., bismuth salt 120 mg q.d.s., rabeprazole 20 mg b.d. for 7 days (7TMBR)
Trial: 12969089
Drug: Tetracycline 500
RxNorm normalized name: oxytetracycline 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline 500 mg q.d.s., metronidazole 500 mg t.d.s., bismuth salt 120 mg q.d.s., rabeprazole 20 mg b.d. for 14 days (14TMBR)
Trial: 10883418
Drug: Fasting treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting treatment
Trial: 1530028
Drug: Exogenous human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exogenous human chorionic gonadotropin 5000 IU administered intramuscularly on luteal day 0 (group II)
Trial: 1530028
Drug: Exogenous human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exogenous human chorionic gonadotropin 5000 IU administered intramuscularly on luteal day +8 (group III)
Trial: 31181357
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 300,000 IU vitamin D before surgery
Trial: 25498218
Drug: Immediate chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate chemotherapy
Trial: 22180399
Drug: Delayed chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed chemotherapy
Trial: 15155323
Drug: Droperidol (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol (placebo capsule preoperatively and IV droperidol 0.625 mg before induction)
Trial: 15155323
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dimenhydrinate LA and droperidol
Trial: 11379334
Drug: amoxicillin, clarithromycin
RxNorm normalized name: Lansoprazole, Amoxicillin, Clarithromycin KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxicillin, clarithromycin and rabeprazole
Trial: 9672795
Drug: PGTP with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGTP with adjunctive subconjunctival 5-fluorouracil (5.0 +/- 1.3 injections of 5 mg each, total of 24.8 mg)
Trial: 9209607
Drug: Rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.6 mg/kg at 50 seconds
Trial: 9209607
Drug: Rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.6 mg/kg at 60 seconds
Trial: 1662637
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg once daily for 3 days (Group I)
Trial: 15316710
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg diazepam
Trial: 7781487
Drug: Carbomer gel
DrugBank: Carbomer (DB15649)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbomer gel Lubrithal (Leo viscous eye gel)
Trial: 24257969
Drug: Early once‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early once‐daily physical therapy plus a novel, progressive, twice‐daily cognitive therapy protocol
Trial: 24257969
Drug: Early once‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early once‐daily physical therapy
Trial: 22409388
Drug: Buprenorphine transdermal
RxNorm normalized name: Buprenorphine Transdermal System
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Buprenorphine transdermal system (BTDS) 20 μg/h
Trial: 18605968
Drug: Tight control
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tight control of hypertension (mean dose of methyldopa 1267±406 mg)
Trial: 1486160
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg flumazenil
Trial: 21933335
Drug: Biopsy recommended
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biopsy recommended due to elevated PSA level (≥ 3 ng/mL)
Trial: 20535457
Drug: AZD0837 450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD0837 450 mg extended‐release formulation once daily for 8 days
Trial: 20535457
Drug: Cimetidine co-administered
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine co-administered on Days 6‐8 during both treatment periods
Trial: 17650832
Drug: High-dose inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose inhaled beclomethasone (1,500 microg/d)
Trial: 16271314
Drug: bupropion XL
RxNorm normalized name: Bupropion Hydrochloride 150 MG Oral Tablet, Extended Release [BUPROPION XL]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: bupropion XL 150-300 mg
Trial: 26654280
Drug: Modafinil (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (200 mg)
Trial: 22787176
Drug: Intensive multifactorial
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive multifactorial treatment
Trial: 23822603
Drug: PROLASTIN (alpha1-proteinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PROLASTIN (alpha1-proteinase inhibitor (human), intravenous)
Trial: 15221407
Drug: Topical heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical heat treatment
Trial: 15221407
Drug: Static stretching
RxNorm normalized name: Mederma Stretch Mark Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Static stretching treatment
Trial: 15221407
Drug: Heat plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat plus static stretching treatment
Trial: 8432269
Drug: Atracurium 0.23
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.23 mg kg‐1
Trial: 27537264
Drug: Ranibizumab plus
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ranibizumab plus intravitreal dexamethasone implant (IVC)
Trial: 27537264
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (IVM and IVC)
Trial: 18475166
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no add-on medication)
Trial: 16609067
Drug: R-CHOP therapy
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-CHOP therapy (n = 113)
Trial: 16609067
Drug: CHOP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHOP therapy (n = 85)
Trial: 16609067
Drug: R-CHOP and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-CHOP and CHOP therapy
Trial: 8641505
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (GnRH‐a) treatment
Trial: 8641510
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of GnRH‐a treatment
Trial: 8641510
Drug: GnRH‐a treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH‐a treatment
Trial: 26746121
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg buspirone
Trial: 24007934
Drug: Carbohydrate-rich fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-rich fluid (Preop(®), 50 kcal/100 ml)
Trial: 22089860
Drug: Single treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single treatment with BCAA
Trial: 22089860
Drug: Single treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single treatment with ACE-I
Trial: 14745283
Drug: rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rabeprazole 20 mg o.d. plus levofloxacin 500 mg o.d. and clarithromycin 250 mg b.d. (RLC-1 group)
Trial: 14745283
Drug: rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rabeprazole 20 mg o.d. plus levofloxacin 500 mg o.d. and clarithromycin 500 mg b.d. (RLC-2 group)
Trial: 11534303
Drug: 20 IU
RxNorm normalized name: Calcium/Phosphorus/Vitamin D 105 MG-81 MG-120 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 IU syntocinon in 20 ml 0.9% NaCl saline intraumbilically (group 1)
Trial: 11534303
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml 0.9% NaCl saline (group 2)
Trial: 2725884
Drug: CY 208-243
RxNorm normalized name: Cys
DrugBank: Cysteine (DB00151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CY 208-243 (5 to 40 mg)
Trial: 4595485
Drug: Fenfluramine (80-120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine (80-120 mg daily)
Trial: 16672046
Drug: Dipyridamole-atropine (Dipatro:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole-atropine (Dipatro: 0.84 mg/kg over 10 min i.v. dipyridamole with addition of up to 1 mg of atropine)
Trial: 15911161
Drug: Rectal placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal placebo (RP)
Trial: 15911161
Drug: Rectal lidocaine
RxNorm normalized name: LIDOCAINE 50 mg in 1 g TOPICAL CREAM [Walgreens Anorectal Lidocaine Cream]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal lidocaine (RL)
Trial: 12150499
Drug: 10-100 mg
RxNorm normalized name: carbidopa
DrugBank: Carbidopa (DB00190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-100 mg sildenafil
Trial: 10458714
Drug: abciximab (12-hour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: abciximab (12-hour administration)
Trial: 10458714
Drug: abciximab (24-hour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: abciximab (24-hour administration)
Trial: 7789047
Drug: Nebulized inhaled
RxNorm normalized name: Hydra-Neb Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized inhaled morphine 25 mg
Trial: 26115618
Drug: Baseline serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline serum adiponectin (mean 14.3 ± 6.6 μg/ml)
Trial: 26115618
Drug: Baseline urine
RxNorm normalized name: Urin DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline urine adiponectin:creatinine (Uadp/cr) (mean 126.8 ± 178.9 μg/ml)
Trial: 23639045
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg lenalidomide
Trial: 18022084
Drug: Assist device
RxNorm normalized name: inhaler, assist devices
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assist device therapy
Trial: 11561270
Drug: Intrathecal mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal mixture containing bupivacaine 0.125% and sufentanil 0.75 microg/mL with epinephrine 1.25 microg/mL
Trial: 11561270
Drug: Intrathecal mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal mixture containing bupivacaine 0.125% and sufentanil 0.75 microg/mL without epinephrine
Trial: 25609219
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 mg loading dose followed by 75 mg maintenance dose)
Trial: 25609219
Drug: Clopidogrel with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel with dronedarone (moderate CYP3A4 inhibitor)
Trial: 9088816
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg, twice, at 12 h intervals (25 patients)
Trial: 22650127
Drug: Comprehensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive treatment group (cotton sheet moxibustion combined with plum-blossom-needle tapping therapy)
Trial: 22650127
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication group (Acyclovir ointment, Valaciclovir Hydrochloride tablets, Vitamin B1)
Trial: 18363746
Drug: Polyphenon E
RxNorm normalized name: Polyphenon E
DrugBank: Sinecatechins (DB01266)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polyphenon E 15% and 10% ointment
Trial: 18363746
Drug: Polyphenon E
RxNorm normalized name: Polyphenon E
DrugBank: Sinecatechins (DB01266)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polyphenon E 10% ointment
Trial: 18363746
Drug: Polyphenon E
RxNorm normalized name: Polyphenon E
DrugBank: Sinecatechins (DB01266)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polyphenon E ointments
Trial: 11677109
Drug: Gemcitabine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine at 1000 mg/m2 days 1 and 8 with carboplatin AUC 4.5
Trial: 11677109
Drug: Gemcitabine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine at 1000 mg/m2 days 1 and 8 with carboplatin AUC 5
Trial: 29603851
Drug: 0.75 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg/d of atrasentan
Trial: 29603851
Drug: 1.25 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg/d of atrasentan
Trial: 23329850
Drug: Live attenuated
RxNorm normalized name: mumps, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live attenuated tetravalent dengue vaccine (LATV)
Trial: 17186795
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate spray 0.05%
Trial: 29098908
Drug: Vehicle spray
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle spray
Trial: 12962529
Drug: Galantamine 24
RxNorm normalized name: galantamine 24 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine 24 mg/day for 12 months (6 months double-blind and 6 months open-label)
Trial: 10831024
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium (target serum concentration of 75 microg/mL for 2 weeks)
Trial: 29257943
Drug: 4% articaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% articaine 1.8 mL as a buccal injection and 0.2 mL as a palatal injection
Trial: 29257943
Drug: 4% articaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% articaine 1.8 mL plus normal saline 0.2 mL as a palatal injection
Trial: 29257943
Drug: 2% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% lidocaine 3.6 mL plus normal saline 0.2 mL as a palatal injection
Trial: 22026393
Drug: Statins (including
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statins (including atorvastatin, pravastatin, rosuvastatin, simvastatin)
Trial: 17520105
Drug: Atorvastatin (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10-40 mg/day)
Trial: 18303246
Drug: Heparin administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin administration within 3 hours from stroke onset
Trial: 17154093
Drug: External irradiation
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External irradiation (as monotherapy)
Trial: 17154093
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (orbital radiation with high-dose intravenous steroid pulse treatment)
Trial: 10753020
Drug: Oral food
RxNorm normalized name: Nutritional Supplement Oral Food, Solid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral food challenges with placebo
Trial: 1558898
Drug: Fenfluramine hydrochloride
RxNorm normalized name: fenfluramine hydrochloride
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine hydrochloride (60 mg/os)
Trial: 26525553
Drug: BG cream
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BG cream with 2-week follow-up (BG1)
Trial: 26525553
Drug: BG cream
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BG cream with 8-week follow-up (BG2)
Trial: 24332263
Drug: RW-SAIL (standardized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RW-SAIL (standardized glycerinated short ragweed sublingual allergen immunotherapy liquid)
Trial: 11422545
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy without cognitive counter conditioning
Trial: 29226626
Drug: GSK2982772 (0.1-120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK2982772 (0.1-120 mg single ascending doses)
Trial: 29226626
Drug: GSK2982772 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK2982772 (20 mg tablets vs capsules)
Trial: 18952910
Drug: 135 mg
RxNorm normalized name: cocaine 135 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 135 mg ABT‐335 alone
Trial: 18952910
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 40 mg rosuvastatin and 135 mg ABT‐335